Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-15-048200
Filing Date
2015-08-11
Accepted
2015-08-11 17:06:45
Documents
1
Effectiveness Date
2015-08-11

Document Format Files

Seq Description Document Type Size
1 DEFA14A v417898_defa14a.htm DEFA14A 15896
  Complete submission text file 0001144204-15-048200.txt   16947
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-27436 | Film No.: 151044679
SIC: 2836 Biological Products, (No Diagnostic Substances)